• Modifying ART in the Presence of Hyperlipidemia: Using HIV-ASSIST

  • Jun 9 2023
  • Length: 12 mins
  • Podcast
Modifying ART in the Presence of Hyperlipidemia: Using HIV-ASSIST By cover art

Modifying ART in the Presence of Hyperlipidemia: Using HIV-ASSIST

Listen for free

View show details

  • Summary

  • In this episode, Maunank Shah, MD, PhD, discusses using HIV-ASSIST to optimize treatment for both HIV and hyperlipidemia. Listen as he covers:

    • Hyperlipidemia and cardiovascular disease risk among people living with HIV
    • Recommendations for lipid screening for people living with HIV
    • Using HIV-ASSIST to support ART treatment decisions for people living with HIV with comorbidities
    • How HIV-ASSIST prioritizes certain ART agents in the setting of hyperlipidemia, including:
      • Deciding between bictegravir, doravirine, dolutegravir, raltegravir, and rilpivirine vs boosted protease inhibitors, including darunavir
      • Deciding between tenofovir disoproxil fumarate and tenofovir alafenamide or abacavir
    • How HIV-ASSIST incorporates drug‒drug interaction data from the University of Liverpool HIV Drug Interactions Checker and the DHHS guidelines when considering the use of statin therapy with ART
    • How HIV-ASSIST further incorporates drug resistance data from the Stanford HIV Drug Resistance Database

    Maunank Shah, MD, PhD 
    Associate Professor 
    Infectious Diseases 
    Johns Hopkins University 
    Baltimore, Maryland 

    Link to full program: bit.ly/3pwaH2Y
    Show more Show less
Show more Show less

What listeners say about Modifying ART in the Presence of Hyperlipidemia: Using HIV-ASSIST

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available